ApoVax 认领应用

ApoVax, Inc. is based on the work of Haval Shirwan, Ph.D. at the University of Louisville.ApoVax104, an immunostimulatory adjuvant construct, consists of streptavidin fused to the costimulatory molecule 4-1BBL. It is well differentiated from other adjuvants. ApoVax104 can be mixed with or conjugated to any biotinylated antigen (or peptide)--cancer or infectious disease. ApoVax is also developing ApoFasL—a means of immunomodulation for tolerance induction—for the treatment of Type 1 diabetes.